RI-AG03 is an orally active peptide inhibitor capable of crossing the blood-brain barrier, targeting Tau aggregation. It effectively inhibits Tau aggregation in both in vivo and in vitro models, improving associated neurodegenerative and behavioral phenotypes. RI-AG03 is applicable in research on Tauopathies such as Alzheimers disease.
Molecular Weight:
2477.93
Formula:
C104H189N49O22
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
